ACR Applauds NRC for Adding IR to Medical Advisory Committee
ACR welcomes a new IR seat on the NRC advisory committee, strengthening expertise for radionuclide therapy, licensing and patient care.
Read moreACR Applauds NRC for Adding IR to Medical Advisory Committee
ACR welcomes a new IR seat on the NRC advisory committee, strengthening expertise for radionuclide therapy, licensing and patient care.
Read moreAC Update Regards Lung Diseases
Stay current with ACR Appropriateness Criteria updates featuring new and revised guidance for lung disease imaging.
Read moreFY27 NIH Appropriations
ACR urges Congress to finalize FY27 NIH funding, protecting biomedical research, medical innovation and advances in patient care.
Read moreThis page was updated Nov. 11 with a revision to the MedPAC section.
ACR® will update this page with any developments that impact radiologists, practices and patients. ACR members, continue to read the ACR Advocacy in Action e-newsletter delivered to in your inbox Saturday mornings.
The following agencies have publicly posted shutdown contingency plans, which are summarized below. Each heading is a direct link to that respective plan.
Centers for Medicare & Medicaid Services (CMS):
Food and Drug Administration (FDA):
National Institutes of Health (NIH):
Advanced Research Projects Agency for Health (ARPA-H):
Centers for Disease Control and Prevention (CDC):
Department of Veterans Affairs (VA):
Nuclear Regulatory Commission (NRC):
We will continue to monitor developments and share updates as available.